- Medicon Valley
- News & Events
- News
- Events
- Medicon Valley Newsletter
- June 2008
- May 2008
- April 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- November 2005
- October 2005
- September 2005
- Business Opportunities
- Science & Research
- Networks
- Services & Support
- Companies & Institutions
- At Your Service
Medicon Valley Biomedical Newsletter
The Medicon Valley Biomedical Newsletter is intended for decision makers in pharmaceutical and biotech companies, investors and other professionals who wish to keep updated on business related activities in the Medicon Valley.
February
The Medicon Valley Biomedical Newsletter February edition is brought to you by Region Skåne and Copenhagen Capacity. The top story this month is that Sweden has been ranked number one, and Denmark number 5 of the European Innovation Scoreboard 2007.
Find more information about this and other top news from Medicon Valley in the newsletter below.
Other news from the region are continuously updated on our webpage: www.mediconvalley.com/NewsAndEvents/News
-
Sweden and Denmark in Top 5 of the European Innovation Scoreboard 2007
22 Feb 2008
Sweden is ranked most innovative country and Denmark is ranked 5th in the European Innovation Scoreboard 2007, EIS 2007. The European Innovation Scoreboard is the instrument developed on the in...
-
Alligator Bioscience and ImmuRx Enter Into Strategic Collaboration
20 Feb 2008
Swedish Alligator Biosciences AB, which develops protein drug candidates, has entered into a strategic collaboration with American biopharmaceutical company Immurx. The latter is developing an adjuvan...
-
BioGaia Signs Further Agreement with Ferring Pharmaceuticals
16 Aug 2007
BioGaia AB has signed an agreement with the Swiss bio-pharmaceutical company Ferring Pharmaceuticals. The agreement gives Ferring exclusive rights to sell BioGaia´s Probiotic Drops in Mexico, Brazil a...
-
Dako Receives FDA Approval of Diagnostic Test for Breast Cancer Patients
29 Jan 2008
The US Food and Drug Administration has given Dako A/S PMA approval to market its TOP2A FISH pharmDx assay. The assay is intended as an adjunct in determining the prognosis for high risk breast cancer...
-
Genmab to Purchase Antibody Manufacturing Facility
22 Feb 2008
Genmab A/S and PDL BioPharma, Inc. have entered into an agreement under which Genmab would acquire PDL's antibody manufacturing facility located in Brooklyn Park, Minnesota, USA for USD 240 millio...
-
Vivolution Acquires Extensive Patent Portfolio from Bristol-Meyers Squibb
25 Jan 2008
ConvaTec, a subsidiary of Bristol-Meyer Squibb, who developed the VivostatSystem, and subsequently sold the project to Vivolution A/S, has agreed to sell all patents covering the Vivostat technology a...
{33A7AE34-CD47-4D46-AF45-37F27279E301}.pdf
Medicon Valley Biomedical Newsletter is published by
Region Skåne and Copenhagen Capacity.
We assist foreign companies in finding locations and partnerships in Medicon Valley. We offer free assistance at each step of the business development phase. Visit www.mediconvalley.com or contact us to learn more about the opportunities that await your company in Medicon Valley.
|
Copenhagen Capacity |
Region Skåne |
If you have any comments on the Medicon Valley Biomedical Newsletter please contact the editor at info@mediconvalley.com.
Here you can subscribe to the Medicon Valley Academy Newsletter
The MVA newsletter is an e-mail news service for Medicon Valley Academy (MVA) members and other actors within life science. The newsletter brings you information on new MVA initiatives and activities, editorials on issues of topical interest, news from the region together with available jobs and relevant life science events.
Click here to subscribe or visit www.mva.org.